Top Markets
#1 ADO Protocol ADO Protocol +334.60%
#2 Islamic Coin Islamic Coin +155.41%
#3 GoPlus Security GoPlus Security +38.11%
#4 Starpower Starpower +37.90%
#5 GAIB AID GAIB AID +24.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.81%
#7 Casper Network Casper Network +14.39%
#8 Ontology Gas Ontology Gas +11.67%
#9 Nockchain Nockchain +11.57%
#10 o1.exchange o1.exchange +10.57%
Coin of the day
ADO Protocol ADO Protocol
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
NightHawk Biosciences, Inc. NightHawk Biosciences, Inc.

NightHawk Biosciences, Inc.

NHWK
Rankning i aktier #33280
NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm,... NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 platform. This platform encompasses two key technologies: ImPACT, an allogeneic (off-the-shelf) cell-based system designed to activate and expand T-cells, acting as a broad immune stimulant; and ComPACT, which combines antigen-specific T-cell activation with targeted co-stimulation in a single product. NightHawk's clinical pipeline features several promising candidates: HS-110, which has completed enrollment for its Phase II clinical trial, targeting advanced non-small cell lung cancer; and HS-130, currently undergoing a Phase I clinical trial for advanced solid tumors. Additionally, PTX-35, a novel T-cell co-stimulator agonist antibody that specifically targets DR3/TNFRSF25, is also in Phase I development. The company is also exploring DR3/TNFRSF25 as a general target for various immunotherapy applications. Beyond these, a COVID-19 vaccine is currently in preclinical stages. A notable collaboration involves Dr. James Shapiro at the University of Alberta, focusing on the manufacturing of a surrogate mouse version of PTX-35. Originally established as Heat Biologics, Inc. in 2008, the company rebranded to NightHawk Biosciences, Inc. in May 2022. Its headquarters are located in Morrisville, North Carolina.
Aktiekurs
$0.3136
Senast synkroniserad: 2024-03-04
Marknadsvärde
$7.97M
Förändring (1 dag)
-3.00%
Förändring (1 år)
0.00%
Land
US
Handel NightHawk Biosciences, Inc. (NHWK)

Kategori

Healthcare
Aktiekurshistorik för NightHawk Biosciences, Inc. (NHWK)
Högsta slutkurs: $0.32 den 2024-03-01

Lägsta slutkurs: $1.61K den 2006-02-01
Aktiekurshistorik för NightHawk Biosciences, Inc. från 2006 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 -12.72%
2023 -62.73%
2022 -74.60%
2021 -38.90%
2020 94.88%
2019 -61.16%
2018 -69.55%
2017 -57.98%
2016 -61.68%
2015 -42.63%
2014 -45.31%
2013 19.58%
2010 39.45%
2009 26.00%
2008 -82.79%
2007 -12.37%
2006 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 7.08%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.26 13.28%
BE